|
|
 |
AngioSense 680, AngioSense-IVM 680 AngioSense 750, AngioSense-IVM 750 |
 |
AngioSPARK 680, AngioSpark 750 |
 |
These agents are based on fluorescent nanoparticles (20-35 nm). With an approximate half-life in plasma of 20 h, they are well suited for prolonged monitoring of blood vessels and observing phenomena such as blood leakage in tumors, inflammation and angiogenesis.
|
|
 |
 |
 |
 |
Excellent for in vitro and in vivo imaging using IVM, FMT, FRI, FACS and fluorescence microscopy
|
 |
 |
 |
Work with superbright, stable fluorescence for longer times than previously possible
|
 |
 |
 |
Ideal for in vivo imaging applications
 |
 |
 |
biocompatible, minimal cytotoxicity, narrow size distribution, highly functionalized
|
|
|
| AngioSPARK 680 |
| AngioSPARK 680 absorbance, excitation and emission spectra in 1 x PBS |
 |
| Particle size |
20-50 nm |
| Fluorescence Excitation |
673 ± 5 nm |
| Fluorescence Emission |
690 ± 5 nm |
| Extinction |
4 x 106 ± 2 x 106 M-1cm-1 |
| Appearance |
Greenish-brown solution |
| AngioSPARK 750 |
| AngioSPARK 750 absorbance, excitation and emission spectra in 1 x PBS |
 |
| Particle size |
20-50 nm |
| Fluorescence Excitation |
750 ± 5 nm |
| Fluorescence Emission |
775 ± 5 nm |
| Extinction |
4 x 106 ± 2 x 106 M-1cm-1 |
| Appearance |
Greenish-brown solution |
Further details of the chemistry behind superbright fluorescence nanoparticles from VisEn
Superhance 680 |
 |
|
|
 |
These are small molecule (1500 MW) fluorescence agents that enable imaging of vascular leakage and circulation including that associated with early oncologic and ophthalmologic lesions. Superhance binds to albumin and has a half-life in plasma of approximately 2 h.
|
| Superhance 680 |
| Superhance 680 absorbance and emission spectra in 1 x PBS |
 |
| MW |
~1540 g mol-1 |
| Fluorescence Excitation |
675 ± 5 nm |
| Fluorescence Emission |
692 ± 5 nm |
| Absorbance |
675 ± 5 nm |
| Purity (determined by RP-HPLC, measuring absorbance at 675 nm) |
>95% |
| Appearance |
Clear blue solution |
Genhance 680 |
 |
| Genhance 680 |
| Genhance 680 absorbance and emission spectra in 1 x PBS |
 |
| MW |
~1140 g mol-1 |
| Fluorescence Excitation |
670 ± 5 nm |
| Fluorescence Emission |
688 ± 5 nm |
| Absorbance |
670 ± 5 nm |
| Extinction |
~100,000 M-1cm-1 |
| Purity (determined by RP-HPLC, measuring absorbance at 670 nm) |
>90% |
| Appearance |
Blue solid |
Genhance 750 |
 |
| Genhance 750 |
| Genhance 750 absorbance and emission spectra in 1 x PBS |
 |
| MW |
~885 g mol-1 |
| Fluorescence Excitation |
750 ± 5 nm |
| Fluorescence Emission |
775 ± 5 nm |
| Absorbance |
750 ± 5 nm |
| Extinction |
~100,000 M-1cm-1 |
| Purity (determined by RP-HPLC, measuring absorbance at 750 nm) |
>90% |
| Appearance |
Blue solid |
 |
 |
Fluorescence Agent Preparation |
The products below are supplied at a concentration recommended for injection, no dilution is required:
| Product |
Supplied/recommended injection concentration |
Recommended injection volume for an ~25 gram mouse |
| AngioSense 680 |
2 nmol/150 μl in 1 x PBS |
150 μl |
| AngioSense 750 |
2 nmol/150 μl in 1 x PBS |
150 μl |
| AngioSense-IVM 680 |
1000 μl in 1 x PBS |
100 μl |
| AngioSense-IVM 750 |
1000 μl in 1 x PBS |
100 μl |
| Superhance 680 |
4 nmol/150 μl in 1 x PBS |
150 μl |
| AngioSPARK 680 |
500 μl in 1 x PBS |
100 μl |
| AngioSPARK 750 |
500 μl in 1 x PBS |
100 μl |
The products below are supplied as solids for dissolution in 1 x PBS (not supplied):
| Product |
Recommended injection concentration |
Recommended injection volume for an ~25 gram mouse |
| Genhance 680 |
0.05 mg/100 μl in 1 x PBS |
100 μl |
| Genhance 750 |
0.05 mg/100 μl in 1 x PBS |
100 μl |
 |
 |
Administration of Fluorescence Agents |
Allow fluorescence agents to reach room temperature before injection. Inject intravenously via the tail vein. Use a small gauge (27G) needle and dispense slowly into the tail vein.
 |
 |
Imaging Time Points |
| Fluorescence agent |
Recommend imaging time post tail vein injection. |
| AngioSense 680 |
0 – 24 hours |
| AngioSense 750 |
0 – 24 hours |
| AngioSense-IVM 680 |
0 – 4 hours |
| AngioSense-IVM 750 |
0 – 4 hours |
| Superhance 680 |
0 – 24 hours |
| Genhance 680 |
0 – 24 hours |
| Genhance 750 |
0 – 24 hours |
| AngioSPARK 680 |
0 – 24 hours* |
| AngioSPARK 750 |
0 – 24 hours* |
* Can be used for up to 12 hours later to image vascular leakage in sites of tumors or inflammation. Can be imaged in the interstitium for up to 24 hours post tail vein injection.
 |
For additional information and application support, please contact us
|